Investors News Releases Sign up for email alerts to receive company and investor updates News Releases Investor Relations Investor Relations News Releases Presentations & Events Common Stock Information Stock Quote & Chart Analyst Coverage SEC Filings Corporate Governance Overview Board of Directors Committee Composition Management Team Annual Reports News Releases Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 May 27 2008 Cyclacel’s Sapacitabine receives orphan designation for AML & MDS from EU regulators May 15 2008 May 2008 Investment Banking Conferences May 09 2008 Cyclacel Pharmaceuticals announces first quarter 2008 financial results Apr 28 2008 Cyclacel Pharmaceuticals announces May 2008 corporate events Apr 16 2008 Cyclacel Pharmaceuticals presents insights into the mechanisms of its cell cycle inhibitor drugs Apr 07 2008 Cyclacel Pharmaceuticals announces multiple presentations at American Association of Cancer Research Annual Meeting Mar 20 2008 Cyclacel Pharmaceuticals invited to present at the BioCentury future leaders conference Mar 11 2008 Cyclacel Pharmaceuticals announces financial results for fourth quarter and year ended December 31, 2007 Mar 05 2008 Cyclacel Pharmaceuticals to announce fourth quarter 2007 financial results on March 11, 2008 Mar 04 2008 Cyclacel's David Glover to present at New York Academy of Sciences Symposium Feb 06 2008 Cyclacel Pharmaceuticals to present at the Annual BIO CEO & Investor Conference Dec 31 2007 Cyclacel initates phase 2 sapacitabine trial in elderly AML patients Dec 18 2007 Update - Cyclacel to host conference call December 19 - Note new time Dec 11 2007 Cyclacel Pharmaceuticals secures $60 million Committed Equity Financing Facility Dec 10 2007 Cyclacel reports updated Phase I sapacitabine data at 2007 ASH meeting Dec 06 2007 Cyclacel Pharmaceuticals to present at the NYSSA 11th Annual Biotech/Specialty Pharma Conference Dec 05 2007 Cyclacel Pharmaceuticals announces Sapacitabine poster presentation at upcoming American Society of Hematology Meeting Nov 26 2007 Cyclacel Pharmaceuticals provides year end 2007 pipeline update and outlines 2008 Key Business Objectives Nov 14 2007 Cyclacel Pharmaceuticals to present at the Lazard Capital Markets 4th Annual Healthcare Conference Nov 07 2007 Cyclacel Pharmaceuticals reports third quarter 2007 financial results and corporate update Nov 02 2007 Cyclacel Pharmaceuticals to announce third quarter 2007 financial results on November 7, 2007 Oct 25 2007 Cyclacel pharmaceuticals to present at the Acumen Biofin Rodman & Renshaw 9th Annual healthcare conference Oct 08 2007 Cyclacel Pharmaceuticals acquires specialty pharmaceutical business focused on the oncology market Oct 02 2007 Cyclacel Pharmaceuticals to present at the 4th Annual BIO Investor Forum Conference Sep 25 2007 Cyclacel Pharmaceuticals to present at the 2007 UBS Global Life Sciences Conference Pagination First page « first Previous page ‹ previous … Page 13 Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Next page next › Last page last » Toolkit Email AlertsRSS FeedsPrint Page
News Releases Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 May 27 2008 Cyclacel’s Sapacitabine receives orphan designation for AML & MDS from EU regulators May 15 2008 May 2008 Investment Banking Conferences May 09 2008 Cyclacel Pharmaceuticals announces first quarter 2008 financial results Apr 28 2008 Cyclacel Pharmaceuticals announces May 2008 corporate events Apr 16 2008 Cyclacel Pharmaceuticals presents insights into the mechanisms of its cell cycle inhibitor drugs Apr 07 2008 Cyclacel Pharmaceuticals announces multiple presentations at American Association of Cancer Research Annual Meeting Mar 20 2008 Cyclacel Pharmaceuticals invited to present at the BioCentury future leaders conference Mar 11 2008 Cyclacel Pharmaceuticals announces financial results for fourth quarter and year ended December 31, 2007 Mar 05 2008 Cyclacel Pharmaceuticals to announce fourth quarter 2007 financial results on March 11, 2008 Mar 04 2008 Cyclacel's David Glover to present at New York Academy of Sciences Symposium Feb 06 2008 Cyclacel Pharmaceuticals to present at the Annual BIO CEO & Investor Conference Dec 31 2007 Cyclacel initates phase 2 sapacitabine trial in elderly AML patients Dec 18 2007 Update - Cyclacel to host conference call December 19 - Note new time Dec 11 2007 Cyclacel Pharmaceuticals secures $60 million Committed Equity Financing Facility Dec 10 2007 Cyclacel reports updated Phase I sapacitabine data at 2007 ASH meeting Dec 06 2007 Cyclacel Pharmaceuticals to present at the NYSSA 11th Annual Biotech/Specialty Pharma Conference Dec 05 2007 Cyclacel Pharmaceuticals announces Sapacitabine poster presentation at upcoming American Society of Hematology Meeting Nov 26 2007 Cyclacel Pharmaceuticals provides year end 2007 pipeline update and outlines 2008 Key Business Objectives Nov 14 2007 Cyclacel Pharmaceuticals to present at the Lazard Capital Markets 4th Annual Healthcare Conference Nov 07 2007 Cyclacel Pharmaceuticals reports third quarter 2007 financial results and corporate update Nov 02 2007 Cyclacel Pharmaceuticals to announce third quarter 2007 financial results on November 7, 2007 Oct 25 2007 Cyclacel pharmaceuticals to present at the Acumen Biofin Rodman & Renshaw 9th Annual healthcare conference Oct 08 2007 Cyclacel Pharmaceuticals acquires specialty pharmaceutical business focused on the oncology market Oct 02 2007 Cyclacel Pharmaceuticals to present at the 4th Annual BIO Investor Forum Conference Sep 25 2007 Cyclacel Pharmaceuticals to present at the 2007 UBS Global Life Sciences Conference Pagination First page « first Previous page ‹ previous … Page 13 Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Next page next › Last page last »
Apr 16 2008 Cyclacel Pharmaceuticals presents insights into the mechanisms of its cell cycle inhibitor drugs
Apr 07 2008 Cyclacel Pharmaceuticals announces multiple presentations at American Association of Cancer Research Annual Meeting
Mar 11 2008 Cyclacel Pharmaceuticals announces financial results for fourth quarter and year ended December 31, 2007
Mar 05 2008 Cyclacel Pharmaceuticals to announce fourth quarter 2007 financial results on March 11, 2008
Dec 06 2007 Cyclacel Pharmaceuticals to present at the NYSSA 11th Annual Biotech/Specialty Pharma Conference
Dec 05 2007 Cyclacel Pharmaceuticals announces Sapacitabine poster presentation at upcoming American Society of Hematology Meeting
Nov 26 2007 Cyclacel Pharmaceuticals provides year end 2007 pipeline update and outlines 2008 Key Business Objectives
Nov 14 2007 Cyclacel Pharmaceuticals to present at the Lazard Capital Markets 4th Annual Healthcare Conference
Nov 07 2007 Cyclacel Pharmaceuticals reports third quarter 2007 financial results and corporate update
Nov 02 2007 Cyclacel Pharmaceuticals to announce third quarter 2007 financial results on November 7, 2007
Oct 25 2007 Cyclacel pharmaceuticals to present at the Acumen Biofin Rodman & Renshaw 9th Annual healthcare conference
Oct 08 2007 Cyclacel Pharmaceuticals acquires specialty pharmaceutical business focused on the oncology market
